home / stock / iova / iova quote
Last: | $12.50 |
---|---|
Change Percent: | 0.25% |
Open: | $11.75 |
Close: | $12.50 |
High: | $12.9974 |
Low: | $11.75 |
Volume: | 5,755,641 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$12.5 | $11.75 | $12.5 | $12.9974 | $11.75 | 5,755,641 | 05-01-2024 |
$11.78 | $11.9 | $11.78 | $12.49 | $11.69 | 4,418,332 | 04-30-2024 |
$12.03 | $11.79 | $12.03 | $12.11 | $11.72 | 4,563,057 | 04-29-2024 |
$11.64 | $11.6 | $11.64 | $11.8 | $11.335 | 2,489,561 | 04-26-2024 |
$11.54 | $11.5 | $11.54 | $11.65 | $11.16 | 3,398,958 | 04-25-2024 |
$11.71 | $11.92 | $11.71 | $12.14 | $11.68 | 2,664,686 | 04-24-2024 |
$11.86 | $11.42 | $11.86 | $11.97 | $11.41 | 3,873,333 | 04-23-2024 |
$11.32 | $11.54 | $11.32 | $11.635 | $11.07 | 2,404,929 | 04-22-2024 |
$11.31 | $11.6 | $11.31 | $11.69 | $11.01 | 5,264,084 | 04-19-2024 |
$11.72 | $11.68 | $11.72 | $11.94 | $11.47 | 3,700,759 | 04-18-2024 |
$11.8 | $11.96 | $11.8 | $12.115 | $11.645 | 3,140,572 | 04-17-2024 |
$11.92 | $11.79 | $11.92 | $12.135 | $11.53 | 5,396,243 | 04-16-2024 |
$11.89 | $12.35 | $11.89 | $12.53 | $11.66 | 6,385,235 | 04-15-2024 |
$12.36 | $13.01 | $12.36 | $13.13 | $12.15 | 4,500,970 | 04-12-2024 |
$13.19 | $12.64 | $13.19 | $13.22 | $12.4901 | 3,756,314 | 04-11-2024 |
$12.58 | $12.66 | $12.58 | $12.73 | $12.11 | 5,652,865 | 04-10-2024 |
$13.22 | $13.07 | $13.22 | $13.3 | $12.91 | 4,225,435 | 04-09-2024 |
$13.07 | $13.59 | $13.07 | $13.59 | $12.89 | 4,660,426 | 04-08-2024 |
$13.53 | $13.48 | $13.53 | $13.89 | $13.2 | 3,383,947 | 04-05-2024 |
$13.6 | $14.08 | $13.6 | $14.21 | $13.4 | 4,096,826 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
SAN CARLOS, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its first quarter 2024 ...
2024-04-28 14:44:00 ET There's a lot of excitement around Iovance Biotherapeutics (NASDAQ: IOVA) as its shares are up over 40% year-to-date. Investors and analysts both see even more upside for this mid-cap biotech stock in the long run. Today, however, the company remains deepl...
SAN CARLOS, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a biote...